Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have shown that extremely high doses (up to 1011 TCID50 per dose) are required to effect a cure. Very high titers of the virus must therefore be achieved during production to ensure an adequate supply. We have previously shown that Measles virus can be produced in Vero cells growing on a Cytodex 1 microcarrier in serum-containing medium using a stirred-tank reactor (STR). However, process optimization and further process transfer or scale up requires the identification of critical process parameters, particularly because the use of STRs increases the risk of cell damage and lower product yields due to shear stress. Using a small-scale STR (0.5 L work...
Large scale continuous cell���line cultures promise greater reproducibility and efficacy for the pro...
Vero cells are nowadays widely used in the production of vaccines. However, they are anchorage depen...
Since the 80´s, microcarriers have been used to provide growth support for adherent cells in vaccine...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Measles virus (MV) with attenuated pathogenicity has potential as oncolytic agent. However, the clin...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Oncolytic viruses can be effective weapons against cancer with few treatment options. For example th...
Oncolytic measles virus (MV) is a promising treatment for cancer but titers of up to 1011 infectious...
Cancer patients can benefit from the Measles virus, since in the early 70s a relation between cancer...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Large scale continuous cell���line cultures promise greater reproducibility and efficacy for the pro...
Vero cells are nowadays widely used in the production of vaccines. However, they are anchorage depen...
Since the 80´s, microcarriers have been used to provide growth support for adherent cells in vaccine...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have sho...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Measles virus (MV) with attenuated pathogenicity has potential as oncolytic agent. However, the clin...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Oncolytic viruses can be effective weapons against cancer with few treatment options. For example th...
Oncolytic measles virus (MV) is a promising treatment for cancer but titers of up to 1011 infectious...
Cancer patients can benefit from the Measles virus, since in the early 70s a relation between cancer...
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinic...
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied...
Large scale continuous cell���line cultures promise greater reproducibility and efficacy for the pro...
Vero cells are nowadays widely used in the production of vaccines. However, they are anchorage depen...
Since the 80´s, microcarriers have been used to provide growth support for adherent cells in vaccine...